NBIX ▲ +0.3% - Neurocrine Biosciences, Inc.
$NBIX NBIX - Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-'567 in Adults with Alzheimer's Disease
20-OCT-2026 08:31 AM ET
Share this post
More filings for $NBIX
NBIX ▲ +0.0% - Neurocrine Biosciences, Inc.Oct 16, 2026NBIX - Neurocrine Biosciences, Inc. - SEC Filing Update (15-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 15, 2026NBIX ▼ -0.7% - Neurocrine Biosciences, Inc.Oct 12, 2026$NBIX SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $NBIX filing history →💬 Comments
Loading comments…
Leave a comment